One very interesting thing I neglected to mention was that Tanzi said that he felt that we would need amyloid imaging to prove there's amyloid in the brain and phosphorylated tau levels in CSF combined with limited or no AB42 in CSF to prove that patients have AD and are in bad shape. Interestingly he is saying amyloid imaging combined with CSF is integral to AD proof. This tells me that he believes that the SUVR results from the IMAGINE trial were useful and only confounded by the placebo fluke.
Tanzi talking!, page-8
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $2.329K | 506.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 61 | 77022239 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 27579259 | 24 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |